Back to Authors

Lincoln, Sarah

A5108784215 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 59

DNMT1 mutation hot spot causes varied phenotypes of HSAN1 with dementia and hearing loss

Neurology | January 31, 2013 | Volume: 80 | Issue: 9 | Pages: 824-828

10.1212/wnl.0b013e318284076d | PMID 23365052

O3‐11‐03: Genetic association of variants with late‐onset Alzheimer's disease risk and brain gene expression

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_12 | Pages: No page available

10.1016/j.jalz.2012.05.1202

O5‐03‐03: Genetic association of progressive supranuclear palsy (PSP) risk loci variants with brain gene expression and neuropathology endophenotypes

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_20 | Pages: No page available

10.1016/j.jalz.2012.05.1983

P1‐201: Identification of human disease‐associated variants in a brain expression genome‐wide association study (eGWAS)

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2012.05.480

Novel late-onset Alzheimer disease loci variants associate with brain gene expression

Neurology | June 22, 2012 | Volume: 79 | Issue: 3 | Pages: 221-228

10.1212/wnl.0b013e3182605801 | PMID 22722634

O3‐01‐08: Evaluation of known Alzheimer's genes for SNPs that influence their brain expression (eSNPs)

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_14 | Pages: No page available

10.1016/j.jalz.2011.05.2392

P1‐229: Genome‐Wide Association Study of Brain Gene Expression Levels (eGWAS)

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_5 | Pages: No page available

10.1016/j.jalz.2011.05.509

Dopamine Transporter Genetic Variants and Pesticides in Parkinson’s Disease

Environmental Health Perspectives | February 21, 2009 | Volume: 117 | Issue: 6 | Pages: 964-969

10.1289/ehp.0800277 | PMID 19590691

Abstract Background Research suggests that independent and joint effects of genetic variability in the dopamine transporter (DAT) locus and pesticides may influence Parkinson’s disease (PD) risk. Materials Methods: In 324 incident PD patients and 334 population controls from our rural California case–control study, we genotyped rs2652510, rs2550956 (for the DAT 5′ clades), and the 3′ variable number of tandem repeats (VNTR). Using geographic information system methods, we determined residential exposure to agricultural maneb and paraquat applications. We also collected occupational pesticide use data. Employing logistic regression, we calculated odds ratios (ORs) for clade diplotypes, VNTR genotype, and number of susceptibility (A clade and 9-repeat) alleles and assessed susceptibility allele–pesticide interactions. Results PD risk was increased separately in DAT A clade diplotype carriers [AA vs. BB: OR = 1.66; 95% confidence interval (CI), 1.08–2.57] and 3′ VNTR 9/9 carriers (9/9 vs. 10/10: OR = 1.8; 95% CI, 0.96–3.57), and our data suggest a gene dosing effect. Importantly, high exposure to paraquat and maneb in carriers of one susceptibility allele increased PD risk 3-fold (OR = 2.99; 95% CI, 0.88–10.2), and in carriers of two or more alleles more than 4-fold (OR = 4.53; 95% CI, 1.70–12.1). We obtained similar results for occupational pesticide measures. Discussion Using two independent pesticide measures, we a) replicated previously reported gene–environment interactions between DAT genetic variants and occupational pesticide exposure in men and b) overcame previous limitations of nonspecific pesticide measures and potential recall bias by employing state records and computer models to estimate residential pesticide exposure. Conclusion Our results suggest that DAT genetic variability and pesticide exposure interact to increase PD risk.
P1‐106: LRRK2 as a common link between tauopathies and synucleinopathies

Alzheimer's & Dementia | July 24, 2008 | Volume: 4 | Issue: 4S_Part_7 | Pages: No page available

10.1016/j.jalz.2008.05.693